VRAX (Virax Biolabs Group) Inventories, Raw Materials & Components: $0.05 Mil (As of Mar. 2026)


VRAX Virax Biolabs Group Ltd VRAX
29 GF Score
Price $3.11
GF Value $1.15
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Virax Biolabs Group Inventories, Raw Materials & Components?

Virax Biolabs Group VRAX +0.65% 29 Inventories, Raw Materials & Components is $0.05 Mil as of Mar. 2026. GuruFocus rates VRAX with a GF Score™ of 29/100 and a GF Value™ of $1.15 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Virax Biolabs Group's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0.05 Mil.

Virax Biolabs Group's quarterly raw materials increased from Mar. 2025 ($0.05 Mil) to Sep. 2025 ($0.05 Mil) but then declined from Sep. 2025 ($0.05 Mil) to Mar. 2026 ($0.05 Mil).

Virax Biolabs Group's annual raw materials increased from Mar. 2024 ($0.00 Mil) to Mar. 2025 ($0.05 Mil) but then stayed the same from Mar. 2025 ($0.05 Mil) to Mar. 2026 ($0.05 Mil).

Virax Biolabs Group Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Virax Biolabs Group's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virax Biolabs Group Inventories, Raw Materials & Components Chart

Virax Biolabs Group Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 0.00 0.00 0.00 0.05 0.05

Virax Biolabs Group Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.05 0.05 0.05 0.05
VRAX
29GF Score
Virax Biolabs Group Ltd VRAX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Virax Biolabs Group Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.05 Mil mean?
Virax Biolabs Group (VRAX) has a Inventories, Raw Materials & Components of $0.05 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Virax Biolabs Group and its competitors.
Is Virax Biolabs Group's Inventories, Raw Materials & Components too high?
Virax Biolabs Group's current Inventories, Raw Materials & Components is $0.05 Mil. Overall, Virax Biolabs Group has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Virax Biolabs Group's Inventories, Raw Materials & Components compare to BBLG and PKTX?
Virax Biolabs Group's Inventories, Raw Materials & Components of $0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Virax Biolabs Group and its competitors. Virax Biolabs Group's current Inventories, Raw Materials & Components is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virax Biolabs Group stock overvalued right now?
Based on GuruFocus' analysis, Virax Biolabs Group (VRAX) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.15, compared to a current price of $3.11 — trading 170.4% above its estimated fair value. The current Inventories, Raw Materials & Components is $0.05 Mil. Virax Biolabs Group's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Virax Biolabs Group (VRAX), the current Inventories, Raw Materials & Components is $0.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virax Biolabs Group (VRAX) Overvalued in 2026?

Based on GuruFocus' analysis, Virax Biolabs Group stock appears to be overvalued. The current stock price of $3.11 is trading 170.4% above its estimated GF Value™ of $1.15. GuruFocus considers Virax Biolabs Group to be Significantly Overvalued.

Key valuation signals for VRAX:

  • Inventories, Raw Materials & Components: $0.05 Mil
  • GF Value™: $1.15 vs. price of $3.11 (170.4% above fair value)
  • GF Score™: 29/100 with 2 warning signs

No single metric tells the full story. See the VRAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virax Biolabs Group Business Description

Address Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
29GF Score

Get the complete analysis for VRAX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.11
Price
$1.15
GF Value